Skip to content

Artificial Intelligence | April 8–10, 2019 | Boston, MA USA

Discovery Cafe Sessions

Tuesday, April 9th, 2019, 11:45 am - 1:00 pm

Location:

Lunch with Experts: Intensive sessions addressing cutting-edge artificial intelligence topics.

Provider Back Office of the Future

The application of AI-based technologies to the business side of health care — including functions such as billing, payment, and insurance claims management — could lead to significant improvements in health care operations and efficiency, with billions of dollars in savings each year. Panelists will discuss emerging tools and technologies as well as the opportunities and pitfalls of using AI to innovate and automate back office functions.

Moderator: Peter Markell, EVP, Administration and Finance, CFO and Treasurer, PHS

Ingeborg Garrison, CNO/VP of Strategic Advisory Services, Verge Health

Kent Ivanoff, CEO, VisitPay

Mary Beth Remorenko, VP, Revenue Cycle Operations, PHS

Brian Robertson, CEO, VisiQuate

 

Chief Digital Strategy Officer Roundtable

With the advent of AI-enabled technologies, this session brings together leading chief digital health officers. The discussion will address tradeoffs in sequencing technology across academic medical centers; what technologies are being prioritized; and consumer expectations.

Moderator: Alistair Erskine, MD, Chief Digital Health Officer, PHS

Michael Anderes, Chief Innovation and Digital Health Officer, Froedtert Health; President, Inception Health

Adam Landman, MD, VP and CIO, BH; Associate Professor of Emergency Medicine, HMS

Aimee Quirk, CEO, innovationOchsner

Richard Zane, MD, Chief Innovation Officer, UCHealth; Professor and Chair,Department of Emergency Medicine, University of Colorado School of Medicine

 

Innovation Fellows: A New Model of Collaboration

The Innovation Fellows Program provides experiential career development opportunities for future leaders in health care. It facilitates personnel exchanges between Harvard Medical School staff from Partners’ hospitals and participating biopharmaceutical, device, venture capital, digital health, payor and consulting firms. Fellows and Hosts learn from each other as they collaborate on projects ranging from clinical development to digital health and artificial intelligence. Learn how this new model of collaboration can deliver value and lead to broader relationships between industry and academia.

Moderator: Seema Basu, PhD, Market Sector Leader, Innovation, PHS

Nathalie Agar, PhD, Research Scientist, Neurosurgery, BH; Associate Professor, Neurosurgery, Radiology, HMS

Paul Anderson, MD, PhD, Chief Academic Officer, BH; SVP, Research, BH; K. Frank Austen Professor of Medicine, HMS

Laurie Braun, MD, Partners Innovation Fellow, MGH and Boston Pharmaceuticals; Instructor in Pediatrics, HMS

David Chiang, MD, PhD, Research Fellow, BH; Innovation Fellow, Boston Scientific

David Feygin, PhD, Chief Digital Health Officer, Boston Scientific

Peter Ho, MD, PhD, CMO, Boston Pharmaceuticals

Harry Orf, PhD, SVP, Research, MGH; Principal Associate, HMS

 

Last Mile: Fully Implementing AI in Healthcare

This session will focus on how radiology and pathology specialties are currently applying AI in the clinic. Where will it be built out first? What are the barriers and how will these challenges be overcome?

Moderator: Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS

Katherine Andriole, PhD, Director of Research Strategy and Operations, MGH & BWH CCDS; Associate Professor, Radiology, HMS

Samuel Aronson, Executive Director, IT, Personalized Medicine, PHS

Peter Durlach, SVP, Healthcare Strategy & New Business Development, Nuance

Seth Hain, VP of R&D, Epic

Jonathan Teich, MD, PhD, Chief Medical Information Officer, InterSystems; Emergency Medicine, BH

 

Reimagining Disease Management

The management of disease has become vastly more challenging, both for patients and providers. AI-based technologies promise to improve and streamline patient care through a variety of approaches. This session will feature a discussion of these new tools and how they can enhance patient engagement and optimize care management.

Moderator: Sree Chaguturu, MD, Chief Population Health Officer, PHS; Assistant Professor, Medicine, HMS

Murray Brozinsky, Chief Strategy Officer, Conversa

Jean Drouin, MD, CEO, Clarify Health Solutions

Julian Harris, MD, President, CareAllies

Erika Pabo, MD, Chief Health Officer, Humana Edge; Associate Faculty, Ariadne Labs; Associate Physician, BH; Instructor, HMS

 

Standards and Regulation: The Emerging AI Framework

As the health care industry faces an explosion of AI-based tools, the FDA’s approach to these technologies is evolving. This session will focus on the agency’s approach to AI-based products, how to calculate the risk profile of these new technologies, and the challenges of securing adequate data rights.

Moderator: Brent Henry, Member, Mintz Levin

Bethany Hills, Member/ Chair, FDA Practice, Mintz Levin

Michelle McMurry-Heath, MD, PhD, VP, Global Regulatory Affairs and International Clinical Evidence, Johnson & Johnson Medical Devices

Bakul Patel, Associate Director, Digital Health, FDA

Michael Spadafore, Managing Director, Sandbox Industries

 

From Startup to Impact (Provider Solutions)

This session will introduce you to five leading startup companies who will each share their respective impact in delivery provider solutions in ten-minute pitches.

Moderator: Meredith Fisher, PhD, Partner, Partners Innovation Fund, PHS

Moderator: James Stanford, Managing Director, Fitzroy Health

William Grambley, COO, AllazoHealth

Gal Salomon, CEO, CLEW

Brian Symmons, COO, Gauss Surgical

Pelu Tran, CEO, Ferrum Health

Ed Zecchini, CIO, Remedy Partners

Scroll To Top